Interestingly, the authors found that anthocyanin-loaded PEG-AuNPs (PEG-AuNPs) were more effective than native anthocyanins in reducing the neuropathological disorder of Alzheimer’s disease via the PI3K/p-Akt/p-GSK3β pathway. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.